Requirement for Q226, but not multiple charged residues, in the class I MHC CD loop/D strand for TCR-activated CD8 accessory function

European Journal of Immunology

Volumn 33, Issue 3, 2003, Pages 676-684

  Durairaj, Micheal ^a   Sharma, Ranjana ^a   Varghese, Jay C ^a   Kane, Kevin P ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

CTL MHC CD8 Adhesion molecule

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR;

ACIDIFICATION; ANIMAL CELL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ANTIGEN PURIFICATION; ANTIGEN RECOGNITION; ANTIGEN STRUCTURE; CELL SURFACE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DEGRANULATION; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; REVIEW; SOLID; TARGET CELL;

ANIMALS; ANTIGENS, CD8; CELL ADHESION; CELL DEGRANULATION; DIMERIZATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; MICE; MICE, INBRED C57BL; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0037352707     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200323499     Document Type: Review

References (32)

1. Dustin, M. L. and Shaw, A. S., Costimulation: building an immunological synapse. Science 1999. 283: 649-650.
2. O'Rourke, A. M. and Mescher, M. F., Cytotoxic T-lymphocyte activation involves a cascade of signalling and adhesion events. Nature 1992. 358: 253-255.
3. Springer, T. A., Adhesion receptors of the immune system. Nature 1990. 346: 425-434.
4. O'Rourke, A. M., Rogers, J. and Mescher, M. F., Activated CD8 binding to class I protein mediated by the T cell receptor results in signalling. Nature 1990. 346: 187-189.
5. Ybarrondo, B., O'Rourke, A. M., Brian, A. A. and Mescher, M. F., Contribution of lymphocyte function-associated-1/intercellular adhesion molecule-1 binding to the adhesion/signaling cascade of cytotoxic T lymphocyte activation. J. Exp. Med. 1994. 179: 359-363.
6. Kane, K. P. and Mescher, M. F, Activation of CD8-dependent cytotoxic T lymphocyte adhesion and degranulation by peptide class I antigen complexes. J. Immunol. 1993. 150: 4788-4797.
7. Connolly, J. M., Potter, T. A., Wormstall, E. M. and Hansen, T. H., The Lyt-2 molecule recognizes residues in the class I alpha 3 domain in allogeneic cytotoxic T cell responses. J. Exp. Med. 1988. 168: 325-341.
8. Potter, T. A., Bluestone, J. A. and Rajan, T. V., A single amino acid substitution in the alpha 3 domain of an H-2 class I molecule abrogates reactivity with CTL. J. Exp. Med. 1987. 166: 956-966.
9. Potter, T. A., Rajan, T. V., Dick, R. F., 2nd and Bluestone, J. A., Substitution at residue 227 of H-2 class I molecules abrogates recognition by CD8-dependent, but not CD8-independent, cytotoxic T lymphocytes. Nature 1989. 337: 73-75.
10. Connolly, J. M., Hansen, T. H., Ingold, A. L. and Potter, T. A., Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I α3 domain: CD8 and the T cell receptor recognize the same class I molecule. Proc. Natl. Acad. Sci. USA 1990. 87: 2137-2141.
11. Salter, R. D., Benjamin, R. J., Wesley, P. K., Buxton, S. E., Garrett, T. P., Clayberger, C., Krensky, A. M., Norment, A. M., Littman, D. R. and Parham, P., A binding site for the T cell coreceptor CD8 on the α3 domain of HLA-A2. Nature 1990. 345: 41-46.
12. b mutant altered at position 222 in the alpha 3 domain. Eur. J. Immunol. 1992. 22: 647-653.
13. Sekimata, M., Tanabe, M., Sarai, A., Yamamoto, J., Kariyone, A., Nakauchi, H., Egawa, K. and Takiguchi, M., Different effects of substitutions at residues 224 and 228 of MHC class I on the recognition of CD8. J. Immunol. 1993. 150: 4416-4426.
14. Sun, J., Leahy, D. J. and Kavathas, P. B., Interaction between CD8 and major histocompatibility complex (MHC) class I mediated by multiple contact surfaces that include the α2 and α3 domains of MHC class I. J. Exp. Med. 1995. 182: 1275-1280.
15. Gao, G. F., Tormo, J., Gerth, U. C., Wyer, J. R., McMichael, A. J., Stuart, D. I., Bell, J. I., Jones, E. Y. and Jakobsen, B. K., Crystal structure of the complex between human CD8α(α) and HLA-A2. Nature 1997. 387: 630-634.
16. b. Immunity 1998. 9: 519-530.
17. Shen, L., Potter, T. A. and Kane, K. P., Glu227→Lys substitution in the acidic loop of major histocompatibility complex class I α3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions. J. Exp. Med. 1996. 184: 1671-1683.
18. d complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120. J. Mol. Biol. 1998. 283: 179-191.
19. Kane, K. P., Sherman, L. A. and Mescher, M. F., Molecular interactions required for triggering alloantigen-specific cytolytic T lymphocytes. J. Immunol. 1989. 142: 4153-4160.
20. b and thymic leukemia antigen, while similarly with their alpha 3 domains. J. Immunol. 2002. 168: 3881-3886.
21. Kane, K. P., Champoux, P. and Mescher, M. F., Solid-phase binding of class I and II MHC proteins: immunoassay and T cell recognition. Mol. Immunol. 1989. 26: 759-768.
22. Daniels, M. A., Devine, L., Miller, J. D., Moser, J. M., Lukacher, A. E., Altman, J. D., Kavathas, P., Hogquist, K. A. and Jameson, S. C., CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. Immunity 2001. 15: 1051-1061.
23. Moody, A. M., Chui, D., Reche, P. A., Priatel, J. J., Marth, J. D. and Reinherz, E. L., Developmentally regulated glycosylation of the CD8alphabeta coreceptor stalk modulates ligand binding. Cell 2001. 107: 501-512.
24. Arcaro, A., Gregoire, C., Bakker, T. R., Baldi, L., Jordan, M., Goffin, L., Boucheron, N., Wurm, F., van der Merwe, P. A., Malissen, B. and Luescher, I. F., CD8β endows CD8 with efficient coreceptor function by coupling T cell receptor/CD3 to raft-associated CD8/p56(lck) complexes. J. Exp. Med. 2001. 194: 1485-1495.
25. Jensen, P. L. and Mescher, M. F., Role of phosphoinositide 3-kinase in TCR-signaled regulation of CD8-mediated adhesion to class I MHC protein. Eur. J. Immunol. 2001. 31: 3612-3621.
26. O'Rourke, A. M., Apgar, J. R., Kane, K. P., Martz, E. and Mescher, M. F., Cytoskeletal function in CD8- and T cell receptor-mediated interaction of cytotoxic T lymphocytes with class I protein. J. Exp. Med. 1991. 173: 241-249.
27. b antigens determined with monoclonal antibodies and H-2 mutant mice. Proc. Natl. Acad. Sci. USA 1982. 79: 4737-4741.
28. Sarmiento, M., Glasebrook, A. L. and Fitch, F. W., IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 1980. 125: 2665-2672.
29. Cobbold, S. P., Jayasuriya, A., Nash, A., Prospero, T. D. and Waldmann, H., Therapy with monoclonal antibodies by elimination of T cell subsets in vivo. Nature 1984. 312: 548-551.
30. Kubo, R. T., Born, W., Kappler, J. W., Marrack, P. and Pigeon, M., Characterization of a monoclonal antibody which detects all murine alpha beta T cell receptors. J. Immunol. 1989. 142: 2736-2742.
31. Kunkel, T. A., Roberts, J. D. and Zakour, R. A., Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 1987. 154: 367-382.
32. b subsets to serve as TCR ligands for allo-specific CTL clones: potential role for N-linked glycosylation. J. Exp. Med. 1995. 181: 1773-1783.